EVH vs. TNET, STNE, CNXC, CARG, FA, ATHM, DLO, HNGE, CLVT, and APLD
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include TriNet Group (TNET), StoneCo (STNE), Concentrix (CNXC), CarGurus (CARG), First Advantage (FA), Autohome (ATHM), DLocal (DLO), Hinge Health (HNGE), Clarivate (CLVT), and Applied Digital (APLD). These companies are all part of the "business services" industry.
Evolent Health vs. Its Competitors
Evolent Health (NYSE:EVH) and TriNet Group (NYSE:TNET) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings.
In the previous week, TriNet Group had 2 more articles in the media than Evolent Health. MarketBeat recorded 4 mentions for TriNet Group and 2 mentions for Evolent Health. TriNet Group's average media sentiment score of 1.26 beat Evolent Health's score of 0.92 indicating that TriNet Group is being referred to more favorably in the news media.
Evolent Health has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, TriNet Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500.
TriNet Group has a net margin of 3.46% compared to Evolent Health's net margin of -2.41%. TriNet Group's return on equity of 200.82% beat Evolent Health's return on equity.
Evolent Health presently has a consensus target price of $17.79, indicating a potential upside of 110.73%. TriNet Group has a consensus target price of $96.67, indicating a potential upside of 22.80%. Given Evolent Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Evolent Health is more favorable than TriNet Group.
96.8% of TriNet Group shares are owned by institutional investors. 1.4% of Evolent Health shares are owned by insiders. Comparatively, 37.1% of TriNet Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
TriNet Group has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than TriNet Group, indicating that it is currently the more affordable of the two stocks.
Evolent Health received 221 more outperform votes than TriNet Group when rated by MarketBeat users. Likewise, 74.90% of users gave Evolent Health an outperform vote while only 66.42% of users gave TriNet Group an outperform vote.
Summary
TriNet Group beats Evolent Health on 13 of the 19 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
This page (NYSE:EVH) was last updated on 6/13/2025 by MarketBeat.com Staff
